Originally published in The Center for Biosimilars Biosimilars have struggled to gain ground in the United States, with few products launched, relatively low uptake of commercially available products, formulary restrictions that sometimes favor branded biologics over biosimilar options, and exclusionary contracting practices that block biosimilars from formularies altogether. A variety of policy proposals have been put forward to help […]
About Articularis Rheumatology Network
This author has yet to write their bio.Meanwhile lets just say that we are proud Articularis Rheumatology Network contributed a whooping 20 entries.
Entries by Articularis Rheumatology Network
By Colin C. Edgerton, M.D. Biosimilar Adoption Falters Rheumatologists hoped that biosimilars would reduce the costs of treating diseases such as rheumatoid arthritis (RA), and thereby increase access to these life altering medications for our patients. The recent Forbes article, “Biosimilars Continue to Exhibit Market Failure” confirms what we as rheumatologists are observing, that biosimilars […]
The field of rheumatology is experiencing a workforce shortage that is expected to worsen in years to come, and many patients living with rheumatic disease already live in medically underserved areas across the nation. Articularis Healthcare is proud to offer care with 12 locations across two states, spanning 11 counties. It’s not uncommon for patients […]
Originally published in PR Web TSI Healthcare, a national leader in the sales and support for NextGen Practice Management (PM) and Electronic Health Records (EHR) solutions partnered with Articularis Rheumatology Network to develop the first electronic payer approved Rheumatoid Arthritis (RA) Pathway. Articularis Rheumatology Network, together with TSI Healthcare, developed the clinical decision support pathway […]
Thank you to everyone that stopped by ARN’s booth at the National Infusion Center Association’s (NICA) conference held in Austin, TX this past week. We’re happy to have connected with so many individuals, and look forward to seeing many of you at #NICA2020!
Originally published in Veterans Health Today Colin C. Edgerton, MD, rheumatologist at Articularis Healthcare in South Carolina and chair of the American College of Rheumatology’s Committee on Rheumatologic Care and former US Army rheumatologist, discusses the prevalence of arthritis among active and former service members as well as the importance of a dedicated arthritis research […]
ARN’s CEO Ray Waldrup is looking forward to exhibiting at the NICA conference in a couple of weeks! Stop by Booth 52 for more information about how ARN GPO works with independent rheumatology practices to increase revenue and reduce expenses, while improving the value of care.
by Ray Waldrup, CEO Medical practices from all over the country visit Articularis Healthcare Group’s (AHG) Charleston, South Carolina locations and are taken back by the efficiency and caliber of AHG employees. Many are also puzzled by the lack of managers and supervisors we employ. Inevitably, someone always asks, “How do you develop and recruit […]
Originally published in March edition of News On Rheumatology Matters (NORM) The healthcare industry has been trying to shift away from the fee-for-service models that can incentivize overutilization towards payment models that reward quality – but these so-called “Alternative Payment Models” have been slow to catch on. However, some practices have embraced the core elements […]
Originally published in Healio Rheumatology The American College of Rheumatology has called for the removal of step therapy, ranked medications and fail-first policies that are based solely on cost. The call to abolish step therapy is one of several recommendations issued by the ACR regarding drug pricing and access. The recommendations were included in two […]